866-997-4948(US-Canada Toll Free)

Drugs of Abuse Testing: Technologies and Global Markets

Published By :

BCC Research

Published Date : Mar 2019

Category :

Pharmaceutical

No. of Pages : 174 Pages

Summary

Globally, the use of illicit drugs is rising every year and has become a significant concern for countries including the U.S., the U.K. Japan, Germany, India and China. Illicit drugs in use include heroin, cannabis, cocaine, ecstasy and amphetamine. Global cocaine seizures increased to 671 tons in 2017, compared with 634 tons seized in 2015. The largest increases in the quantities of cocaine seized occurred in South America and western and central Europe. New psychoactive substances (NPSs) such as phenethylamines, ketamine, piperazine and tryptamines are also used widely in the illicit drug market. Drug trafficking is a global illicit trade involving the cultivation, manufacture, distribution and sale of substances that are subject to drug prohibition laws. According to estimates by the United Nations Office on Drugs and Crime (UNODC), drug trafficking is increasing worldwide due to the rising demand for illicit drugs (mainly heroin, cocaine and amphetamines). World heroin consumption and seizures amount to 430 to 450 tons annually.

According to data from the UNODC and the European crime-fighting agency Europol, the global drug trade is worth about $REDACTED million per year. The annual cocaine trade is worth $REDACTED million. With the exception of opiate use, use of all other groups of substances (opioids, cannabis, cocaine, ATS andecstasy) remains at a level higher than the global average in the Europe region. In the U.S., illicit druguse by persons aged 12 years or older reached the highest level, increasing from REDACT.ED% in 2015 to REDACTED% in 2017

The overall demand for drug of abuse testing is rising. DOA testing is used most heavily by healthcare service providers, public and private organizations and other government agencies. The two main technologies used for onsite screening testing and laboratory testing of drugs of abuse are immunoassay techniques and chromatography.
Table of Contents
Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Intended Audience
Scope of Report
Information Sources and Methodology
Geographic Breakdown
Analysts Credentials
BCC Custom Research
Related BCC Research Reports
Chapter 2 Summary and Highlights
Market Context for Drug Testing
Chapter 3 Market and Technology Background
Single Tests vs. Multiparameter Tests
DOA Screening
Confirmation Testing
Urine Tests
Other Testing Methods
Blood Testing
Oral Fluid Testing
Saliva Testing
Sweat Testing
Hair Testing
Testing Locations
Laboratory-based DAT
Point-of-Care DATs
Onsite Testing
Sample Types for Laboratory Testing
Urine Testing
Hair Testing
Saliva/Oral Fluid Testing
Blood Testing
Sweat Testing
Eye Reflex
Detection Period
Fooling a Drug Test
Fooling Urine Testing
Fooling Hair Testing
Fooling Saliva Testing
Sample Validity Tests
False Positives and False Negatives
False Positives
False Negatives
Drug Clearance and Testing Window
Testing Technologies
Immunoassays
Enzyme Immunoassay (EIA)
Enzyme-linked Immunosorbent Assay (ELISA)
Enzyme Multiplied Immunoassay Technology (EMIT)
Fluorescence Polarization Immunoassay (FPIA)
Radioimmunoassay (RIA)
Chromatography
Eye Reflex Measurements
Chapter 4 Market Dynamics
Drug Abuse Testing
Factors Affecting the Market for DOA Testing
Drivers of the DOA Testing Market
Restraints in the DOA Testing Market
Chapter 5 Regulatory Scenario
North America
Canada
Mexico
U.S.
State-level Marijuana Legalization
U.S. Department of Transportation
Drug Testing in the Military
Drug Testing for Welfare Recipients and Public Assistance
Drug Testing for Individuals Convicted of Drug Felonies
South America
Bolivia
Brazil
Colombia
Ecuador
Guyana
Paraguay
Peru
Central America and the Caribbean
Costa Rica
Cuba
El Salvador
Guatemala
Haiti
Jamaica
Nicaragua
Panama
Honduras
The Bahamas
The Netherlands Antilles
Trinidad and Tobago
Europe
Bosnia and Herzegovina
Denmark
France
Germany
Italy
Latvia
Norway
Romania
Sweden
Switzerland
The Netherlands
The U.K.
Asia-Pacific
Australia
Bangladesh
Bhutan
Cambodia
Hong Kong
India
Japan
Maldives
Myanmar
Nepal
New Zealand
Singapore
South Korea
Sri Lanka
Taiwan
Thailand
Vietnam
Chapter 6 Global Drugs of Abuse Testing Market by Sample Type
Introduction
Global Sales of Urine DOA Testing
Global Sales of Blood DOA Testing
Global Sales of Oral Fluid DOA Testing
Global Sales of Hair DOA Testing
Global Sales of Sweat DOA Testing
Global Sales of DOA Testing Using Other Sample Types
Chapter 7 Global Drugs of Abuse Testing Market by Region
Regional Analysis
Total DOA Testing and Drug Monitoring Markets and Forecasts
North America
Trends in the Trafficking and Use of Illicit Drugs
Europe
Trends in the Trafficking and Use of Illicit Drugs in Europe
Rest of the World
Trends in the Use and Trafficking of Illicit Drugs in Rest of the World
Chapter 8 Global Drugs of Abuse Testing Market by Testing Type
Growth Trends in Laboratory-Based and Onsite DOA Testing Markets
Laboratory-based DOA Testing Market and Forecast
Onsite DOA Testing Market and Forecast
Chapter 9 Patent Analysis
Chapter 10 Competitive Landscape
Competitive Analysis
Key Developments
Key Market Players in the DOA Testing Market and Their Products
Laboratory-Based DOA Testing Market Segment
Onsite DOA Testing Market Segment
Common DOA and Popular Devices for Testing Them
Companies in the Oral Fluid, Hair and Sweat DOA Testing Segments
Chapter 11 Company Profiles
ONE STEP DETECT ASSOCIATES
ABBOTT DIAGNOSTICS
ACCUTECH
ACON LABORATORIES INC.
AGILENT TECHNOLOGIES
ALFA SCIENTIFIC
AMERICAN BIO MEDICA
BECKMAN COULTER
BIOPHOR DIAGNOSTICS
BIO-RAD LABORATORIES
BIOSCAN SCREENING SYSTEMS
CONFIRM BIOSCIENCES
DANAHER CORP.
DEVON MEDICAL PRODUCTS
ELITECH GROUP
EXPRESS DIAGNOSTICS INTERNATIONAL INC.
HOFFMANN-LA ROCHE, LTD.
IDENTA CORP.
LIFELOC TECHNOLOGIES
LIFESIGN
MAVAND SOLUTIONS
MEDTEST DX
MEDTOX DIAGNOSTICS
MOSSMAN ASSOCIATES
MP BIOMEDICALS
NANO-DITECH CORP.
ORASURE
ORTHO CLINICAL DIAGNOSTICS
POLYMED THERAPEUTICS
PRECHEK BIO
PRINCETON BIOMEDITECH
PSYCHEMEDICS
QUEST DIAGNOSTICS INC.
RANDOX LABORATORIES
REDWOOD TOXICOLOGY LABORATORY
SHIMADZU CORP.
SIEMENS HEALTHINEERS
THERMO FISHER SCIENTIFIC
UCP BIOSCIENCES
Chapter 12 Acronyms

List of Table

List of Tables
Summary Table : Global Market for DOA Testing, by Sample Matrix, Through 2023
Table 1 : Cutoff Concentrations for Initial and Confirmatory Drug Tests in Urine
Table 2 : Comparison of Federal Workplace Drug Testing and Clinical Drug Testing
Table 3 : Advantages and Disadvantages of Point-of-Care Testing
Table 4 : Major Advantages and Disadvantages of Onsite Testing
Table 5 : Advantages and Disadvantages of Various Matrices for Drug of Abuse Testing
Table 6 : Detection Periods for Various Types of Drug Testing
Table 7 : Common Parameters Tested for Urine Specimen Validity
Table 8 : Some of the Commercial/Common Adulterants Used in Fooling Urine Tests and Their Effects
Table 9 : Common Parameters Tested for Urine Specimen Validity
Table 10 : Commercial/Common Adulterants Used in Fooling Urine Tests and Their Effects
Table 11 : Methods for Testing Urine Sample Validity
Table 12 : Cross Reactants That Can Lead to False Positives in DOA Testing
Table 13 : Clearance Rates for Common DOA
Table 14 : Commonly Abused Drugs
Table 15 : Global Number of Illicit Drug Users, 2016
Table 16 : Number of Drug-related Deaths, Mortality Rates per Million Persons Aged 1564 Years and Ranking of Drugs as Primary Cause of Death (2016 or Latest Year Available), 2002-2017
Table 17 : Estimated Number of Drug-Related Deaths and Mortality Rates per Million Persons Aged 15-64 Years, by Region, 2018
Table 18 : Annual Prevalence, by Region, 2016
Table 19 : U.S. Drug Testing Legislations, by State, 2017
Table 20 : Marijuana Legalization in Selected State, 2016
Table 21 : European Drug Testing Legislation, by Country
Table 22 : Global Market Share for DOA Testing, by Sample Type, 2017-2023
Table 23 : Global Market for DOA Testing, by Sample Type, Through 2023
Table 24 : Urine DOA Testing Products, by Major Players
Table 25 : Global Market for Urine DOA Testing, by Region, Through 2023
Table 26 : Global Market for Urine DOA Testing: Laboratory-based versus Onsite, Through 2023
Table 27 : Blood DOA Testing Products, by Major Players
Table 28 : Global Market for Blood DOA Testing, by Region, Through 2023
Table 29 : Global Market for Oral Fluid DOA Testing, by Region, Through 2023
Table 30 : Global Market for Oral Fluid DOA Testing: Laboratory-based versus Onsite, Through 2023
Table 31 : Global Market for Hair DOA Testing, by Region, Through 2023
Table 32 : Global Market for Sweat DOA Testing, by Region, Through 2023
Table 33 : Global Market for Other DOA Testing Sample Types, by Region, Through 2023
Table 34 : Global Market for DOA Testing, by Region, Through 2023
Table 35 : North American Market for DOA Testing, by Sample Type, Through 2023
Table 36 : Drug Abuse Statistics in the U.S., by Drug Type (Aged 12 and Older), 2016 and 2017
Table 37 : U.S. Types of Illicit Drug Use in Lifetime, Past Year, and Past Month Among Persons Aged 18 or Older, 2016 and 2017
Table 38 : U.S. Illicit Drug Use in Lifetime, Past Year, and Past Month, by Detailed Age Category, 2016 and 2017
Table 39 : U.S. Marijuana Use in Lifetime, Past Year, and Past Month, by Detailed Age Category, 2016 and 2017
Table 40 : European Market for DOA Testing, by Sample Type, Through 2023
Table 41 : Annual Prevalence of Opioid Use as a Percentage of the Population Aged 15 to 64, by Country, 2018
Table 42 : Annual Prevalence of Cocaine Use as a Percentage of the Population Aged 15 to 64, by Country, 2018
Table 43 : Annual Prevalence of Cannabis Use as a Percentage of the Population Aged 15 to 64, by Country, 2018
Table 44 : Annual Prevalence of ATS Use as a Percentage of the Population Aged 15 to 64, by Country, 2018
Table 45 : Annual Prevalence of Ecstasy Use as a Percentage of the Population Aged 15 to 64, by Country, 2018
Table 46 : RoW Market for DOA Testing, by Sample Type, Through 2023
Table 47 : Global Market for DOA Testing, by Testing Type, Through 2023
Table 48 : Global Market for Laboratory-Based DOA Testing, Through 2023
Table 49 : Global Market for Onsite DOA Testing, Through 2023
Table 50 : Selected U.S. Patents Granted for DOA Testing, 2007-2018
Table 51 : Ranking of Companies in the DOA Testing Market, 2018
Table 52 : Most Notable Mergers and Acquisitions in the DOA Testing Market, 2000-2018
Table 53 : Major Companies and Their Products in the DOA Testing Market
Table 54 : Companies Offering Laboratory-based DOA Testing Products
Table 55 : Main Players in the Onsite DOA Testing Market and Their Products
Table 56 : Common DOA and Popular Urine Drug Screening Products
Table 57 : Key Market Players Offering DOA Testing Products on Oral Fluid, Hair and Sweat Sample Types
Table 58 : One Step Detect Associates: DOA Testing Product Portfolio
Table 59 : Abbott Diagnostics: Financials, 2015-2017
Table 60 : ACON Laboratories Inc.: Financials, 2015-2017
Table 61 : Agilent Technologies: Revenue, 2015-2017
Table 62 : ALFA Scientific: DOA Testing Product Portfolio
Table 63 : ABMC: DOA Testing Product Portfolio
Table 64 : Bio-Rad Laboratories: DOA Testing Product Portfolio
Table 65 : Confirm Biosciences: DOA Testing Product Portfolio
Table 66 : Express Diagnostics International Inc.: DOA Testing Product Portfolio
Table 67 : IDenta Corp.: DOA Testing Product Portfolio
Table 68 : LifeSign: DOA Testing Product Portfolio
Table 69 : MedTest DX: DOA Testing Product Portfolio
Table 70 : MEDTOX Diagnostics: DOA Testing Product Portfolio
Table 71 : MP Biomedicals: DOA Testing Product Portfolio
Table 72 : OraSure: DOA Testing Product Portfolio
Table 73 : Prechek Bio: DOA Testing Product Portfolio
Table 74 : Princeton BioMeditech: DOA Testing Product Portfolio
Table 75 : Psychemedics: DOA Testing Product Portfolio
Table 76 : Quest Diagnostics Inc.: DOA Testing Product Portfolio
Table 77 : Redwood Toxicology Laboratory: DOA Testing Product Portfolio
Table 78 : Thermo Fisher Scientific: Recent Financials, 2016-2017
Table 79 : Thermo Fisher Scientific: DOA Testing Product Portfolio
Table 80 : UCP Biosciences: DOA Testing Product Portfolio
Table 81 : Acronyms Used for Drug Testing: Technologies and Global Markets

List of Chart

List of Figures
Summary Figure : Global Market Share for DOA Testing, by Sample Matrix, 2018 and 2023
Figure 1 : Annual Prevalence of the Use of Amphetamines and Prescription Stimulants, by Region, 2018
Figure 2 : Annual Prevalence of the Use of Cannabis, by Region, 2018
Figure 3 : Annual Prevalence of the Use of Cocaine, by Region, 2018
Figure 4 : Illicit Cultivation of Opium Poppy, 2006-2017*
Figure 5 : Global Market for DOA Testing, by Sample Type, 2017-2023
Figure 6 : Global Market for Urine DOA Testing, by Region, 2016-2023
Figure 7 : Global Market for Urine DOA Testing: Laboratory-based versus Onsite, 2016-2023
Figure 8 : Global Market for Blood DOA Testing, by Region, 2016-2023
Figure 9 : Global Market for Oral Fluid DOA Testing, by Region, 2016-2023
Figure 10 : Global Market for Oral Fluid DOA Testing: Laboratory-based versus Onsite, 2016-2023
Figure 11 : Global Market for Hair DOA Testing, by Region, 2016-2023
Figure 12 : Global Market for Sweat DOA Testing, by Region, 2016-2023
Figure 13 : Global Market for Other DOA Testing Sample Types, by Region, 2016-2023
Figure 14 : Global Market Share for Drugs of Abuse Testing, by Region, 2017
Figure 15 : Abbott Diagnostics: Recent Financials, 2015-2017
Figure 16 : Abbott Diagnostics: Revenue Share, by Business Segment, 2017
Figure 17 : Abbott Diagnostics: Revenue Share, by Country, 2017
Figure 18 : ACON Laboratories Inc.: Financials, 2015-2017
Figure 19 : Agilent Technologies: Revenue Share, by Region/Country, 2017
Figure 20 : Agilent Technologies: Revenue Share, by Business Segment, 2017
Figure 21 : Thermo Fisher Scientific: Recent Financials, 2015-2017
Figure 22 : Thermo Fisher Scientific: Revenue Share, by Business Segment, 2017
Figure 23 : Thermo Fisher Scientific: Revenue Share, by Region, 2017

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *